Home
Storia in 2 fonti
Novo hikes guidance on Wegovy pill’s fast sales start
In its latest earnings report, the Danish drugmaker said sales and profit should shrink less than the company originally anticipated thanks to strong prescription numbers for its new obesity pill.
- ·
cnbc.com
Novo Nordisk’s Wegovy head start on pills forces investors to rethink Eli Lilly's GLP-1 dominance
Early signs from the launch of Novo Nordisk's Wegovy pill and Eli Lilly & Co.'s Foundayo are making investors rethink the opportunity for GLP-1 pills.
- ·
Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance
Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.
- ·
Novo Nordisk CEO: Aim is to expand weight-loss market in U.S.
Charlotte Reed speaks with Mike Doustdar, CEO of Novo Nordisk, after the Danish comapny hiked its 2026 full-year guidance on the back of increased expectations for GLP-1 product…
- ·
biopharmadive.com
Novo hikes guidance on Wegovy pill’s fast sales start
In its latest earnings report, the Danish drugmaker said sales and profit should shrink less than the company originally anticipated thanks to strong prescription numbers for its…